ACCENTIA BIOPHARMACEUTICALS Canadian Trademark Information

On Wednesday, December 21, 2005, a canadian trademark registration was filed for ACCENTIA BIOPHARMACEUTICALS by Accentia Biopharmaceuticals, I *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1284179. The current status of this trademark filing is Interruption of proceeding. The ACCENTIA BIOPHARMACEUTICALS trademark is filed in the description of Pharmaceutical preparations for use in the diagnosis, cure, mitigation, treatment and prevention of diseases and conditions, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, non-hodgkins lymphoma, B-cell non-hodgkins lymphoma, allergies, cough, cold, inflammation, fever, nausea and vomiting; pharmaceutical preparations for the treatment and mitigation of pain; and biologic product preparations not for use with diabetes associated conditions, namely proteins, antibodies, vaccine compositions for human use, cell based products namely cytokines, hormones, morphogens and interleukins, growth factors, antifungals, antitussives and decongestants; Scientific devices for the development, production and proliferation of proteins not for use with diabetes associated conditions, namely bioreactors for automated cell culture and protein production, automated protein purification systems, cultureware consisting of disposable inserts for said bioreactors and purification systems; replacement parts for said bioreactors and purification systems; and control systems for use with said bioreactors and purification systems; Drug delivery systems for use with pharmaceutical, preparations for the cure, mitigation, treatment and prevention of diseases and conditions, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, non-hodgkins lymphoma, b-cell non-hodgkins lymphoma, allergies, cough, cold, inflammation, fever, nausea and vomiting. , Business consultation in the field of commercialization of pharmaceuticals not for use with diabetes associated conditions; distributorship in the field of pharmaceutical products not for use with diabetes associated conditions; pharmaceutical drug development services not in the field of diabetes. , Business consultation in the field of commercialization of pharmaceuticals not for use with diabetes associated conditions; distributorship in the field of pharmaceutical products not for use with diabetes associated conditions; pharmaceutical drug development services not in the field of diabetes. , Pharmaceutical preparations for use in the diagnosis, cure, mitigation, treatment and prevention of diseases and conditions, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, non-hodgkins lymphoma, B-cell non-hodgkins lymphoma, allergies, cough, cold, inflammation, fever, nausea and vomiting; pharmaceutical preparations for the treatment and mitigation of pain; and biologic product preparations not for use with diabetes associated conditions, namely proteins, antibodies, vaccine compositions for human use, cell based products namely cytokines, hormones, morphogens and interleukins, growth factors, antifungals, antitussives and decongestants; Scientific devices for the development, production and proliferation of proteins not for use with diabetes associated conditions, namely bioreactors for automated cell culture and protein production, automated protein purification systems, cultureware consisting of disposable inserts for said bioreactors and purification systems; replacement parts for said bioreactors and purification systems; and control systems for use with said bioreactors and purification systems; Drug delivery systems for use with pharmaceutical, preparations for the cure, mitigation, treatment and prevention of diseases and conditions, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, non-hodgkins lymphoma, b-cell non-hodgkins lymphoma, allergies, cough, cold, inflammation, fever, nausea and vomiting. , Business consultation in the field of commercialization of pharmaceuticals not for use with diabetes associated conditions; distributorship in the field of pharmaceutical products not for use with diabetes associated conditions; pharmaceutical drug development services not in the field of diabetes. , Pharmaceutical preparations for use in the diagnosis, cure, mitigation, treatment and prevention of diseases and conditions, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, non-hodgkins lymphoma, B-cell non-hodgkins lymphoma, allergies, cough, cold, inflammation, fever, nausea and vomiting; pharmaceutical preparations for the treatment and mitigation of pain; and biologic product preparations not for use with diabetes associated conditions, namely proteins, antibodies, vaccine compositions for human use, cell based products namely cytokines, hormones, morphogens and interleukins, growth factors, antifungals, antitussives and decongestants; Scientific devices for the development, production and proliferation of proteins not for use with diabetes associated conditions, namely bioreactors for automated cell culture and protein production, automated protein purification systems, cultureware consisting of disposable inserts for said bioreactors and purification systems; replacement parts for said bioreactors and purification systems; and control systems for use with said bioreactors and purification systems; Drug delivery systems for use with pharmaceutical, preparations for the cure, mitigation, treatment and prevention of diseases and conditions, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, non-hodgkins lymphoma, b-cell non-hodgkins lymphoma, allergies, cough, cold, inflammation, fever, nausea and vomiting. .